๐Ÿ•ต๏ธ Blossomhill Therapeutics, Inc. ($BLSM)

SEC insider & ownership activity, last 12 months ยท CIK 1839970 ยท every row links its SEC filing

Insider buy value was withheld pending verification over the last 12 months. No red-flag 8-Ks in the window.

Insider flow

6 buyers, value withheld pending verification (7 lots) ยท 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Orbimed Advisors LLC1$10.0M 0โ€“Aug 10, 2026
Carl L. Gordon1$10.0M 0โ€“Aug 10, 2026
Chen Bihua1$5.0M 0โ€“Aug 10, 2026
John P. Schmid1$96K 0โ€“Aug 10, 2026
Liptak Vincent Paul2value withheld pending verification 0โ€“Aug 10, 2026
Jason A. Keyes1$11K 0โ€“Aug 10, 2026

5%+ holders

HolderStakeClassScheduleEvent
Chen Bihua 11.8% 13DAug 6, 2026 filing โ†—
Cormorant Asset Management, LP 11.8% 13DAug 6, 2026 filing โ†—
Orbimed Advisors LLC 8.9% 13DAug 10, 2026 filing โ†—
OrbiMed Capital GP VIII LLC 8.9% 13DAug 10, 2026 filing โ†—
Perceptive Advisors LLC 5.9% 13GAug 14, 2026 filing โ†—
Joseph Edelman 5.9% 13GAug 14, 2026 filing โ†—
Perceptive Life Sciences Master Fund, Ltd. 5.9% 13GAug 14, 2026 filing โ†—
VIVO Innovation Fund II Holdings, L.P. 5.5% 13GAug 17, 2026 filing โ†—
VIVO Innovation II, LLC 5.5% 13GAug 17, 2026 filing โ†—

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Earnings (2.02)Sep 18, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Sep 18, 2026 filing โ†—
Reg FD disclosure (7.01)Sep 15, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Sep 15, 2026 filing โ†—
Charter/bylaw changes (5.03)Aug 10, 2026 filing โ†—
Other events (8.01)Aug 10, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Aug 10, 2026 filing โ†—